ELTPOTCPharmaceutical PreparationsFiscal year ends March 31
ELITE PHARMACEUTICALS INC /NV/
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.25−0.00 (-1.37%)
Close on Oct 19, 2026
- Market cap
- $283.02M
- P/E (TTM)
- 5.0
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
0.0%
0M of 1.08B shares
Institutional holders
1
0 new, 0 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
1 buys · 0 sales
Net bought $8.70K
Shares held by institutions
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ELTP | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Wall Street Access Asset Management, LLC | 1,000 | 0.00% | $365 | +500 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | 0M | 0.0% | 0 / 1 | 0 / 0 | 0M | 0M |
| Q1 2026 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q4 2025 | 1 | 0M | 0.0% | 0 / 0 | 0 / 1 | 0M | 0M |
| Q3 2025 | 2 | 0M | 0.0% | 1 / 0 | 0 / 0 | 0M | 0M |
| Q2 2025 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q1 2025 | 1 | 0M | 0.0% | 1 / 0 | 0 / 0 | 0M | 0M |
| Q4 2023 | 0 | 0M | 0.0% | 0 / 0 | 0 / 1 | 0M | 0M |
| Q3 2023 | 1 | 0M | 0.0% | 1 / 0 | 0 / 0 | 0M | 0M |
| Q2 2023 | 0 | 0M | 0.0% | 0 / 0 | 0 / 1 | 0M | 0M |
| Q1 2023 | 1 | 0M | 0.0% | 1 / 0 | 0 / 0 | 0M | 0M |
| Q4 2022 | 0 | 0M | 0.0% | 0 / 0 | 0 / 2 | 0M | 1M |
| Q3 2022 | 2 | 1M | 0.1% | 0 / 0 | 0 / 0 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Douglas Plassche | EVP Operations | 6,000,000 | 0.56% | Jan 13, 2026 |
| Pharmaceuticals Inc /Nv/ Elite | EVP Operations | 4,300,000 | 0.40% | Aug 26, 2025 |
| Kirko Kirkov | Chief Commercial Officer | 16,366 | 0.00% | Jul 25, 2025 |
| Barry H. Dash | Director | 3,265,555 | 0.30% | Sep 10, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Barry H. Dash Director | Aug 19, 2026 | Buy | +30,000 | $0.29 | $8.70K | 3,265,555 |
| Douglas Plassche EVP Operations | Jan 9, 2026 | Option exercise | +2,500,000 | $0.03 | $75.00K | 6,000,000 |
| Douglas Plassche EVP Operations | Oct 2, 2025 | Sale | −800,000 | $0.62 | $496.00K | 3,500,000 |
| Pharmaceuticals Inc /Nv/ Elite EVP Operations | Aug 25, 2025 | Option exercise | +2,500,000 | $0.03 | $75.00K | 4,300,000 |
| Pharmaceuticals Inc /Nv/ Elite EVP Operations | Aug 22, 2025 | Sale | −500,000 | $0.52 | $260.00K | 1,800,000 |
| Kirko Kirkov Chief Commercial Officer | Jul 10, 2025 | Buy | +16,366 | $0.59 | $9.66K | 16,366 |
| Douglas Plassche EVP Operations | Jul 8, 2025 | Sale | −200,000 | $0.58 | $116.00K | 2,300,000 |
| Douglas Plassche EVP Operations | Jul 3, 2025 | Option exercise | +2,500,000 | $0.03 | $75.00K | 2,500,000 |
| Douglas Plassche SVP of Operations | Oct 24, 2024 | Sale | −333,932 | $0.51 | $170.31K | 0 |
| Douglas Plassche SVP of Operations | Oct 23, 2024 | Sale | −800,000 | $0.49 | $392.00K | 333,932 |
| Nasrat A. Hakim CEO, President, Director, 10% owner | Mar 29, 2024 | Award | +49,534,368 | – | – | 216,649,250 |
| Nasrat A. Hakim CEO, President, Director, 10% owner | Dec 29, 2023 | Award | +2,223,147 | $0.07 | $155.62K | 2,223,147 |
| Davis S. Caskey Director | Nov 22, 2023 | Award | +547,657 | $0.04 | $21.91K | 2,049,436 |
| Barry H. Dash Director | Nov 22, 2023 | Award | +547,657 | $0.04 | $21.91K | 3,235,555 |
| Jeffrey A. Whitnell Director | Nov 22, 2023 | Award | +547,657 | $0.04 | $21.91K | 3,187,020 |
| Barry H. Dash Director | Aug 28, 2022 | Award | +459,536 | $0.04 | $18.38K | 2,687,898 |
| Davis S. Caskey Director | Aug 28, 2022 | Award | +459,536 | $0.04 | $18.38K | 1,501,779 |
| Jeffrey A. Whitnell Director | Aug 28, 2022 | Award | +459,536 | $0.04 | $18.38K | 2,639,363 |
| Davis S. Caskey Director | Jun 30, 2021 | Award | +295,570 | $0.07 | $20.69K | 1,042,243 |
| Jeffrey A. Whitnell Director | Jun 30, 2021 | Award | +295,570 | $0.07 | $20.69K | 2,179,827 |
| Barry H. Dash Director | Jun 30, 2021 | Award | +295,570 | $0.07 | $20.69K | 2,228,182 |
| Nasrat A. Hakim CEO & President, Director, 10% owner | Aug 24, 2020 | Conversion | +158,017,321 | – | – | 167,114,882 |
| Barry H. Dash Director | Aug 20, 2020 | Award | +516,781 | $0.09 | $46.51K | 1,932,612 |
| Jeffrey A. Whitnell Director | Aug 20, 2020 | Award | +516,781 | $0.09 | $46.51K | 1,884,257 |
| Davis S. Caskey Director | Aug 20, 2020 | Award | +516,781 | $0.09 | $46.51K | 746,673 |
| Douglas Plassche SVP Operations | Aug 20, 2020 | Award | +71,739 | $0.09 | $6.46K | 1,133,932 |
| Douglas Plassche SVP of Operations | Jun 30, 2020 | Award | +574,597 | $0.09 | $51.71K | 1,062,193 |
| Carter Julian Ward CFO, Sec., Treas. | Feb 26, 2018 | Award | +242,060 | $0.12 | $29.05K | 2,127,364 |
| Jeffrey A. Whitnell Director | Feb 26, 2018 | Award | +161,374 | $0.12 | $19.36K | 1,367,476 |
| Davis S. Caskey Director | Feb 26, 2018 | Award | +161,374 | $0.12 | $19.36K | 229,892 |
| Barry H. Dash Director | Feb 26, 2018 | Award | +161,374 | $0.12 | $19.36K | 1,415,831 |
| Eugene M. Pfeifer Director | Feb 26, 2018 | Award | +161,374 | $0.12 | $19.36K | 233,414 |
| Douglas Plassche SVP of Operations | Feb 26, 2018 | Award | +201,717 | $0.12 | $24.21K | 487,596 |
| Nasrat A. Hakim CEO & President, Director, 10% owner | Apr 28, 2017 | Other | −158,017,321 | – | – | 9,097,561 |
| Davis S. Caskey Director | Feb 23, 2017 | Award | +68,518 | $0.20 | $13.70K | 68,518 |
| Nasrat A. Hakim CEO & President, Director, 10% owner | Feb 23, 2017 | Award | +2,216,992 | $0.23 | $509.91K | 24,143,785 |
| Jeffrey A. Whitnell Director | Feb 23, 2017 | Award | +88,679 | $0.23 | $20.40K | 1,206,102 |
| Carter Julian Ward Director | Feb 23, 2017 | Award | +133,019 | $0.23 | $30.59K | 1,885,304 |
| Barry H. Dash Director | Feb 23, 2017 | Award | +88,679 | $0.23 | $20.40K | 1,254,457 |
| Eugene M. Pfeifer Director | Feb 23, 2017 | Award | +72,040 | $0.20 | $14.41K | 72,040 |
| Douglas Plassche SVP of Operations | Feb 23, 2017 | Award | +110,849 | $0.23 | $25.50K | 285,879 |
| Nasrat A. Hakim CEO & President, Director, 10% owner | Aug 17, 2016 | Option exercise | +142,857,143 | – | – | 142,971,097 |
| Carter Julian Ward CFO, Secretary, Treasurer | Apr 28, 2016 | Conversion | +666,667 | $0.06 | $40.00K | 1,752,285 |
| Jeenarine Narine – | Apr 13, 2016 | Conversion | +4,000,000 | $0.06 | $240.00K | 16,742,395 |
| Jerry Treppel – | Mar 18, 2016 | Sale | −258,090 | $0.34 | $87.75K | 7,640,561 |
| Jerry Treppel – | Mar 17, 2016 | Sale | −312,430 | $0.35 | $109.35K | 7,898,651 |
| Jerry Treppel – | Feb 24, 2016 | Sale | −100,456 | $0.31 | $31.14K | 8,211,081 |
| Jerry Treppel – | Feb 22, 2016 | Sale | −100,000 | $0.32 | $32.00K | 8,311,537 |
| Jerry Treppel – | Feb 17, 2016 | Sale | −50,000 | $0.31 | $15.50K | 8,411,537 |
| Jeffrey A. Whitnell Director | Feb 16, 2016 | Award | +81,549 | $0.25 | $20.39K | 1,117,423 |
| Carter Julian Ward CFO, Sec., Treas | Feb 16, 2016 | Award | +122,325 | $0.25 | $30.58K | 1,085,618 |
| Nasrat A. Hakim Chairman, CEO, President, Director, 10% owner | Feb 16, 2016 | Award | +2,854,279 | $0.25 | $713.57K | 22,040,747 |
| Jerry Treppel – | Feb 16, 2016 | Award | +124,646 | $0.25 | $31.16K | 8,461,537 |
| Barry H. Dash Director | Feb 16, 2016 | Award | +81,549 | $0.25 | $20.39K | 1,165,778 |
| Jeenarine Narine Director | Feb 16, 2016 | Award | +81,549 | $0.25 | $20.39K | 12,742,395 |
| Douglas Plassche Exec Vice Pres Operations | Feb 16, 2016 | Award | +47,767 | $0.26 | $12.42K | 175,030 |
| Jerry Treppel – | Feb 5, 2016 | Sale | −24,400 | $0.33 | $8.05K | 8,336,891 |
| Jerry Treppel – | Feb 4, 2016 | Sale | −349,660 | $0.32 | $111.89K | 8,361,291 |
| Jerry Treppel – | Feb 3, 2016 | Sale | −45,518 | $0.33 | $15.02K | 8,710,951 |
| Jerry Treppel – | Feb 2, 2016 | Sale | −13,000 | $0.33 | $4.29K | 8,756,469 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Douglas Plassche Officer | Aug 22, 2025 | 100,000 | $555.00K | Aug 22, 2025 | Stock Options Exercise |
| Douglas Plassche Officer | Jul 8, 2025 | 500,000 | $303.00K | Jul 8, 2025 | Stock Options Exercise |
| Douglas Plassche Officer | Oct 23, 2024 | 1,133,932 | $680.36K | Oct 23, 2024 | Payment for Services Rendered |